Carsten Thiel - Net Worth and Insider Trading

Carsten Thiel Net Worth

The estimated net worth of Carsten Thiel is at least $7 Million dollars as of 2024-11-13. Carsten Thiel is the EVP, Chief Commercial Officer of Alexion Pharmaceuticals Inc and owns about 37,643 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $7 Million. Details can be seen in Carsten Thiel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carsten Thiel has not made any transactions after 2017-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Carsten Thiel

To

Carsten Thiel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carsten Thiel owns 3 companies in total, including Karyopharm Therapeutics Inc (KPTI) , Abeona Therapeutics Inc (ABEO) , and Alexion Pharmaceuticals Inc (ALXN) .

Click here to see the complete history of Carsten Thiel’s form 4 insider trades.

Insider Ownership Summary of Carsten Thiel

Ticker Comapny Transaction Date Type of Owner
KPTI Karyopharm Therapeutics Inc 2018-08-31 director
ABEO Abeona Therapeutics Inc 2018-03-29 Chief Executive Officer
ALXN Alexion Pharmaceuticals Inc 2017-02-28 EVP & Chief Commercial Officer

Carsten Thiel Latest Holdings Summary

Carsten Thiel currently owns a total of 1 stock. Carsten Thiel owns 37,643 shares of Alexion Pharmaceuticals Inc (ALXN) as of February 28, 2017, with a value of $7 Million.

Latest Holdings of Carsten Thiel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2017-02-28 37,643 182.50 6,869,848

Holding Weightings of Carsten Thiel


Carsten Thiel Form 4 Trading Tracker

According to the SEC Form 4 filings, Carsten Thiel has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 125 shares on February 28, 2017, which brought Carsten Thiel around $9,315.

Insider Trading History of Carsten Thiel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carsten Thiel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carsten Thiel Ownership Network

Ownership Network List of Carsten Thiel

No Data

Ownership Network Relation of Carsten Thiel

Insider Network Chart

Carsten Thiel Owned Company Details

What does Karyopharm Therapeutics Inc do?

Who are the key executives at Karyopharm Therapeutics Inc?

Carsten Thiel is the director of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP Sales & Commercial Ops Sohanya Roshan Cheng .

Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary

Over the past 18 months, Carsten Thiel made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 165,682 shares made by Richard A. Paulson , a net sale of 55,845 shares made by Michael Mason , and a net sale of 41,559 shares made by Sohanya Roshan Cheng .

In summary, during the past 3 months, insiders sold 27,326 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 27,326 shares. During the past 18 months, 2,078,182 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,037,042 shares.

Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Karyopharm Therapeutics Inc Insider Transactions

No Available Data

Carsten Thiel Mailing Address

Above is the net worth, insider trading, and ownership report for Carsten Thiel. You might contact Carsten Thiel via mailing address: C/o Alexion Pharmaceuticals, 352 Knotter Drive, Cheshire Ct 06410.